Abzu helped discover biomarkers for a successful clinical trial.
Our simple models accurately predicted and explained treatment responses for Checkmate Pharmaceuticals
Abzu increased safe lead candidates by 20%
Abzu increased safe lead candidates by 20% for top-10 pharmaceutical company.
Abzu increased safe lead candidates by 20% for an undisclosed top-10 pharmaceutical company.
